Logo image of RCS

PIMCO STRATEGIC INCOME FUND (RCS) Stock Price, Quote, News and Overview

NYSE:RCS - New York Stock Exchange, Inc. - US72200X1046 - Currency: USD

6.94  -0.01 (-0.14%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to RCS. RCS was compared to 0 industry peers in the Unkown industry. RCS has a bad profitability rating. Also its financial health evaluation is rather negative. RCS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

RCS had positive earnings in the past year.
In the past year RCS had a positive cash flow from operations.
In multiple years RCS reported negative net income over the last 5 years.
Of the past 5 years RCS 4 years had a positive operating cash flow.
RCS Yearly Net Income VS EBIT VS OCF VS FCFRCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

Industry RankSector Rank
ROA 3.27%
ROE 14.43%
ROIC 4.69%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RCS Yearly ROA, ROE, ROICRCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

RCS's Profit Margin has improved in the last couple of years.
In the last couple of years the Operating Margin of RCS has declined.
RCS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 69.18%
PM (TTM) 103.57%
GM 67.5%
OM growth 3Y-10.13%
OM growth 5Y-2.84%
PM growth 3Y-14.52%
PM growth 5Y9.24%
GM growth 3Y-10.14%
GM growth 5Y-2.85%
RCS Yearly Profit, Operating, Gross MarginsRCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

More info and screens

1

2. Health

2.1 Basic Checks

RCS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RCS Yearly Shares OutstandingRCS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
RCS Yearly Total Debt VS Total AssetsRCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

RCS has an Altman-Z score of -0.40. This is a bad value and indicates that RCS is not financially healthy and even has some risk of bankruptcy.
RCS has a debt to FCF ratio of 2.65. This is a good value and a sign of high solvency as RCS would need 2.65 years to pay back of all of its debts.
RCS has a Debt/Equity ratio of 0.60. This is a neutral value indicating RCS is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 2.65
Altman-Z -0.4
ROIC/WACCN/A
WACCN/A
RCS Yearly LT Debt VS Equity VS FCFRCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

RCS has a Current Ratio of 0.39. This is a bad value and indicates that RCS is not financially healthy enough and could expect problems in meeting its short term obligations.
RCS has a Quick Ratio of 0.39. This is a bad value and indicates that RCS is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.39
RCS Yearly Current Assets VS Current LiabilitesRCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.08% over the past year.
The Earnings Per Share has been growing slightly by 1.59% on average over the past years.
The Revenue has been growing slightly by 6.78% in the past year.
Measured over the past years, RCS shows a decrease in Revenue. The Revenue has been decreasing by -5.48% on average per year.
EPS 1Y (TTM)5.08%
EPS 3Y-18.36%
EPS 5Y1.59%
EPS Q2Q%-11.11%
Revenue 1Y (TTM)6.78%
Revenue growth 3Y-2.68%
Revenue growth 5Y-5.48%
Sales Q2Q%8.23%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RCS Yearly Revenue VS EstimatesRCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.19 indicates a reasonable valuation of RCS.
Compared to an average S&P500 Price/Earnings ratio of 26.92, RCS is valued rather cheaply.
Industry RankSector Rank
PE 11.19
Fwd PE N/A
RCS Price Earnings VS Forward Price EarningsRCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 7.16
EV/EBITDA N/A
RCS Per share dataRCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)7.05
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.13%, RCS is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.43, RCS pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.13%

5.2 History

RCS has paid a dividend for at least 10 years, which is a reliable track record.
RCS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
RCS Yearly Dividends per shareRCS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

RCS pays out 86.21% of its income as dividend. This is not a sustainable payout ratio.
DP86.21%
EPS Next 2YN/A
EPS Next 3YN/A
RCS Yearly Income VS Free CF VS DividendRCS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
RCS Dividend Payout.RCS Dividend Payout, showing the Payout Ratio.RCS Dividend Payout.PayoutRetained Earnings

More info and screens

PIMCO STRATEGIC INCOME FUND

NYSE:RCS (6/27/2025, 8:04:00 PM)

6.94

-0.01 (-0.14%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners17.68%
Inst Owner Change3.14%
Ins OwnersN/A
Ins Owner Change0%
Market Cap323.75M
Analysts0
Price TargetN/A
Short Float %1.33%
Short Ratio4.53
Dividend
Industry RankSector Rank
Dividend Yield 7.13%
Yearly Dividend0.54
Dividend Growth(5Y)N/A
DP86.21%
Div Incr Years0
Div Non Decr Years3
Ex-Date06-12 2025-06-12 (0.04)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.19
Fwd PE N/A
P/S 11.56
P/FCF 7.16
P/OCF 7.16
P/B 1.61
P/tB 1.61
EV/EBITDA N/A
EPS(TTM)0.62
EY8.93%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.97
FCFY13.97%
OCF(TTM)0.97
OCFY13.97%
SpS0.6
BVpS4.31
TBVpS4.31
PEG (NY)N/A
PEG (5Y)7.05
Profitability
Industry RankSector Rank
ROA 3.27%
ROE 14.43%
ROCE 9.38%
ROIC 4.69%
ROICexc 4.69%
ROICexgc 4.82%
OM 69.18%
PM (TTM) 103.57%
GM 67.5%
FCFM 161.54%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-10.13%
OM growth 5Y-2.84%
PM growth 3Y-14.52%
PM growth 5Y9.24%
GM growth 3Y-10.14%
GM growth 5Y-2.85%
F-Score6
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 2.65
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.43
Cash Conversion N/A
Profit Quality 155.97%
Current Ratio 0.39
Quick Ratio 0.39
Altman-Z -0.4
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.08%
EPS 3Y-18.36%
EPS 5Y1.59%
EPS Q2Q%-11.11%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.78%
Revenue growth 3Y-2.68%
Revenue growth 5Y-5.48%
Sales Q2Q%8.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.16%
EBIT growth 3Y-12.55%
EBIT growth 5Y-8.16%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.32%
OCF growth 3YN/A
OCF growth 5YN/A